Bridging the gap between aggregate data and individual patient management: A Bayesian approach

International Journal of Technology Assessment in Health Care

Volumn 27, Issue 2, 2011, Pages 133-138

  Van Der Wilt, Gert Jan ^a   Groenewoud, Hans ^a   Van Riel, Piet ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bayesian reasoning; Drug treatment; Evidence based medicine; Individual patient management; Rheumatoid arthritis

Indexed keywords

BAYES' THEOREM; BAYESIAN APPROACHES; BAYESIAN REASONING; CLINICAL MANAGEMENT; EVIDENCE-BASED MEDICINE; FULLY COMPATIBLE; GOLD STANDARDS; HEALTH ASSESSMENTS; LIKELIHOOD RATIOS; PATIENT MANAGEMENT; POSTERIOR PROBABILITY; PRIOR PROBABILITY; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

BAYESIAN NETWORKS; DRUG THERAPY; HEALTH; RATING; SURVEYS;

PROBABILITY;

METHOTREXATE; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BAYES THEOREM; BIOMEDICAL TECHNOLOGY ASSESSMENT; DIAGNOSTIC REASONING; DISEASE ACTIVITY SCORE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; PATIENT CARE; PROBABILITY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT RESPONSE; ALGORITHM; DECISION SUPPORT SYSTEM; DRUG ANTAGONISM; ETHICS; EVIDENCE BASED MEDICINE; HEALTH SURVEY; INFORMATION PROCESSING; INSTRUMENTATION; METHODOLOGY; QUESTIONNAIRE; REGISTER; STATISTICAL MODEL;

ALGORITHMS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BAYES THEOREM; DATA COLLECTION; DECISION SUPPORT SYSTEMS, CLINICAL; EVIDENCE-BASED MEDICINE; HEALTH STATUS INDICATORS; HUMANS; LIKELIHOOD FUNCTIONS; METHOTREXATE; PATIENT CARE; QUESTIONNAIRES; REGISTRIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79961101181     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462311000110     Document Type: Article

References (19)

1. Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med. 2009;360:1927-1929.
2. Barrera P, Van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis. Rheumatology (Oxford). 2002;41:430-439.
3. Birnbaum MH. Bayesian calculator. 1999. http://psych.fullerton. edu/mbirnbaum/bayes/BayesCalc.htm (accessed December 10, 2010).
4. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167-178.
5. Emery P, Breedveld FC, Hall S, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial. Lancet. 2008;372:375-382.
6. Fransen J, van Riel PC. The disease activity score and EULAR response criteria. Clin Exp Rheumatol. 2005;23(Suppl 39):S93-S99.
7. Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine? N Engl J Med. 2009;360:1925-1927.
8. Gelman A. Objections to Bayesian statistics. Bayesian Analysis. 2008;3:445-450.
9. Goodman SN. Toward evidence-based medical statistics.1: The P value fallacy. Ann Intern Med. 1999;130:995-1004.
10. Goodman SN. Introduction to Bayesian methods I: Measuring the strength of evidence. Clin Trials. 2005;2:282-290.
11. Greenhalgh T, Worrall JG. From EBM to CSM: The evolution of context-sensitive medicine. J Eval Clin Pract. 1997;3:105-108.
12. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365:1500-1505.
13. Kuper H, Nicholson A, Kivimaki M, et al. Evaluating the causal relevance of diverse risk markers: Horizontal systematic review. BMJ. 2009;339:b4265.
14. Naik AD, Petersen LA. The neglected purpose of comparative effectiveness research. N Engl J Med. 2009;360:1929-1931.
15. Sackett DL, Rosenberg WM, Gray JA, et al Evidence based medicine: What it is and what it isn't. BMJ. 1996;312:71-72.
16. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;56:1424-1432.
17. van Gestel A, Prevoo ML, van 't Hoff MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39:34-40.
18. van Randen A, Bipat S, Zwinderman AH. Acute appendicitis: Meta-analysis of diagnostic performance of CT and graded compression US related to prevalence of disease. Radiology. 2008;249:97-106.
19. Welsing PM, van Riel PL. The Nijmegen inception cohort of early rheumatoid arthritis. J Rheumatol Suppl. 2004;69:14-21.